Search

Your search keyword '"Pelttari, Liisa M."' showing total 245 results

Search Constraints

Start Over You searched for: Author "Pelttari, Liisa M." Remove constraint Author: "Pelttari, Liisa M."
245 results on '"Pelttari, Liisa M."'

Search Results

1. NTHL1 is a recessive cancer susceptibility gene

2. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.

3. Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study

4. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

5. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

6. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

7. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

8. Evidence of a genetic link between endometriosis and ovarian cancer

9. RAD51B in Familial Breast Cancer.

10. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.

11. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.

12. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

13. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

14. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

15. Evidence of a genetic link between endometriosis and ovarian cancer

16. Supplementary Table 5 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

17. Supplementary Table 1 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

18. Data from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

19. Supplementary Table 2 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

20. Supplementary Table 3 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

21. Supplementary Table 4 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

22. Data from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

23. Supplementary Figure 1 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

24. Supplementary Tables S1-6, Figures S1-2 from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

25. Data from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

26. Supplementary Tables 1 - 5 from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

28. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

32. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

33. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

34. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer

35. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci

38. Ovarian and Breast Cancer Risks Associated with Pathogenic Variants in RAD51C and RAD51D

39. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

40. Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients

41. Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients

42. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

43. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

44. RAD51B in Familial Breast Cancer

45. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

47. Genome-wide significant risk associations for mucinous ovarian carcinoma (vol 47, pg 888, 2015)

48. CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

49. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

50. FANCM c.5101C > T mutation associates with breast cancer survival and treatment outcome

Catalog

Books, media, physical & digital resources